ATOPIC DERMATITIS ACROSS THE LIFESPAN: PATHOGENESIS AND THERAPEUTIC HORIZONS

Authors

  • Sarbayeva Chinorakhan Shavkatbekovna Department of Dermatovenerology, Andijan State Medical Institute, Uzbekistan, Andijan Author

Keywords:

Keywords: To analyze the clinical, genetic, and therapeutic landscape of AD, a systematic narrative synthesis was conducted.

Abstract

Atopic dermatitis (AD) is a highly prevalent, chronic inflammatory skin disease that represents a major global public health and socioeconomic burden, affecting up to twenty percent of children and ten percent of adults worldwide. Pathophysiologically, the disease is characterized by a complex, bimodal lifespan trajectory driven by a multifaceted, dynamic interplay of epidermal barrier dysfunction, innate and adaptive immune dysregulation, and microbial dysbiosis. The clinical presentation undergoes distinct age-dependent transitions, progressing from acute, Th17-skewed extensor lesions in infancy to chronic, Th22- and Th1-skewed flexural plaques in adulthood. Furthermore, early-life skin barrier impairment frequently initiates the "atopic march," sequentially predisposing children to food allergies, asthma, and allergic rhinitis, with longitudinal trajectories displaying significant racial and socioeconomic variations.

 

Downloads

Published

2026-09-23